US 11,987,608 B2
Composition for accelerating cell proliferation comprising erythropoietin-derived peptide
Che Il Moon, Daegu (KR); So Yeon Kim, Daegu (KR); Seung Jun Yoo, Gyeongsangbuk-do (KR); and Bong Ki Cho, Daegu (KR)
Assigned to SYLUS CO., LTD., Jeollabuk-do (KR)
Appl. No. 17/271,609
Filed by SYLUS CO., LTD., Jeollabuk-do (KR)
PCT Filed Aug. 21, 2019, PCT No. PCT/KR2019/010615
§ 371(c)(1), (2) Date Feb. 26, 2021,
PCT Pub. No. WO2020/045886, PCT Pub. Date Mar. 5, 2020.
Claims priority of application No. 10-2018-0100580 (KR), filed on Aug. 27, 2018.
Prior Publication US 2021/0340206 A1, Nov. 4, 2021
Int. Cl. C07K 14/505 (2006.01); A61P 7/06 (2006.01); C12N 5/079 (2010.01); A61K 38/00 (2006.01)
CPC C07K 14/505 (2013.01) [A61P 7/06 (2018.01); C12N 5/0618 (2013.01); A61K 38/00 (2013.01); C12N 2501/14 (2013.01)] 10 Claims
 
1. A peptide consisting of the sequence of SEQ ID NO: 27.